---
figid: PMC8914342__fonc-12-848296-g003
figtitle: Emerging Roles and Mechanisms of lncRNA FOXD3-AS1 in Human Diseases
organisms:
- Danio rerio
- Toxoplasma gondii
- Apis mellifera
- Anacardium occidentale
- Annona squamosa
- Garrulax canorus
- Homo sapiens
- Mus musculus
- Human gammaherpesvirus 4
pmcid: PMC8914342
filename: fonc-12-848296-g003.jpg
figlink: /pmc/articles/PMC8914342/figure/f3/
number: F3
caption: The impact of FOXD3-AS1 on chemoresistance. In non-small cell lung cancer
  A549 or H1299 cells, FOXD3-AS1 promotes cisplatin-resistance via inhibiting miR-127-3p
  expression and upregulating MDM2 expression. FOXD3-AS1 also enhances 5-fluorouracil
  resistance via activating ELAVL1 and the PI3K/Akt pathway. In breast cancer T47D
  or MCF7 cells, FOXD3-AS1 intensifies tamoxifen (TMX) resistance via clearing microRNA-363
  and strengthening TFF1 and the PI3K/Akt signaling pathway. In neuroblastoma IMR32
  or BE (2)-C cells, FOXD3-AS1 enhances the sensitivity of all-trans-retinoic-acid
  (ATRA) via repressing PARP1 and CTCF.
papertitle: Emerging Roles and Mechanisms of lncRNA FOXD3-AS1 in Human Diseases.
reftext: Qinfan Yao, et al. Front Oncol. 2022;12:848296.
year: '2022'
doi: 10.3389/fonc.2022.848296
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: long noncoding RNA | FOXD3-AS1 | clinicopathological feature | function
  | mechanism
automl_pathway: 0.9505237
figid_alias: PMC8914342__F3
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
redirect_from: /figures/PMC8914342__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8914342__fonc-12-848296-g003.html
  '@type': Dataset
  description: The impact of FOXD3-AS1 on chemoresistance. In non-small cell lung
    cancer A549 or H1299 cells, FOXD3-AS1 promotes cisplatin-resistance via inhibiting
    miR-127-3p expression and upregulating MDM2 expression. FOXD3-AS1 also enhances
    5-fluorouracil resistance via activating ELAVL1 and the PI3K/Akt pathway. In breast
    cancer T47D or MCF7 cells, FOXD3-AS1 intensifies tamoxifen (TMX) resistance via
    clearing microRNA-363 and strengthening TFF1 and the PI3K/Akt signaling pathway.
    In neuroblastoma IMR32 or BE (2)-C cells, FOXD3-AS1 enhances the sensitivity of
    all-trans-retinoic-acid (ATRA) via repressing PARP1 and CTCF.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FOXD3-AS1
  - IMPACT
  - TFF1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - SLC7A1
  - ELAVL1
  - MDM2
  - PARP1
  - CTCF
  - Impact
  - 11T
  - Tff1
  - Pik3r1
  - Akt1
  - Elavl1
  - Mdm2
  - Parp1
  - Ctcf
  - impact
  - elavl1a
  - mdm2
  - parp1
  - ctcf
---
